Home
Expertise
Therapeutic Areas
Capabilities
Recruitment
Task Forces
About Us
Leadership
Locations
News
Participate
Contact Us
Join a Study
Home
Expertise
Therapeutic Areas
Capabilities
Recruitment
Task Forces
About Us
Leadership
Locations
News
Participate
Contact Us
Home
Expertise
Therapeutic Areas
Capabilities
Recruitment
Task Forces
About Us
Leadership
Locations
News
Participate
Contact Us
Join a Study
Home
Expertise
Therapeutic Areas
Capabilities
Recruitment
Task Forces
About Us
Leadership
Locations
News
Participate
Contact Us
CenExel
Insights
,
On the Record
August 28, 2023
FDA Approves ABRYSVO for RSV
Read More
Insights
,
On the Record
August 12, 2023
Placebo and Nocebo Response Mitigation
Read More
Insights
,
On the Record
July 25, 2023
CenExel FCR Wins Best of the Best
Read More
On the Record
July 15, 2023
Stuart Goldblatt Joins CenExel as CEO
Read More
Case Studies
,
Insights
,
On the Record
December 30, 2022
Emraclidine for the treatment of schizophrenia
Read More
Insights
,
On the Record
December 28, 2022
Primer on the Autonomic Nervous System
Read More
Insights
,
On the Record
November 29, 2022
CenExel CNS Opens Center in Los Alamitos, California
Read More
On the Record
November 15, 2022
CenExel Creates Clinical Sciences Business Unit
Read More
Insights
,
On the Record
November 3, 2022
Psychedelic Facilitators Undergo Certification Training
Read More
Insights
,
On the Record
September 22, 2022
Characterizing human abuse potential (HAP) liability
Read More
Previous
Page
1
Page
2
Next
Search Here
Categories
Case Studies
Insights
On the Record
Multimedia
White Papers
